Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
...
Next
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Sep 16, 2022 4:54pm
RE:SBM barely holding that 17 cent low from early June
Great fall planned I hear. So, as usual, we go again. You always show up just before.
(10)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Sep 16, 2022 2:46pm
RE:RE:RE:Feline patent action for BOEHRINGER INGELHEIM ANIMAL HEALTH
Pareto, so true and nothing really to add.
Discover Options Trading Strategies to Minimize your Tax Burden
posted Dec 01, 2024 9:00am by
Bank of Montreal
-
|
Options trading doesn’t come without tax implications, but there are ways investors can still optimize their after-tax returns with just a little bit of understanding. Approaches for investors to keep in mind are holding periods, wash-sales rule, tax advantaged accounts, and qualified cover calls. BMO’s enhanced InvestorLine platform. Industry-leading tools and capabilities specifically designed to empower options traders. ...read more
(14)
•••
hcdtrading
X
View Profile
View Bullboard History
Post by
hcdtrading
on Sep 16, 2022 2:36pm
SBM barely holding that 17 cent low from early June
That level gets taken out then its just that 14 cent low last December to hold. No volume = no interest. Volume has dried again since that little run mid June. This stock has only had 2 good
...more
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Sep 16, 2022 2:20pm
RE:RE:Feline patent action for BOEHRINGER INGELHEIM ANIMAL HEALTH
You would think with the Allergan "MEGA" deal, pending clinical trial for their Botox killer (according to HV), pending deal for in the feline diabetes realm, new application of their SGLT2,
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Sep 16, 2022 9:18am
RE:Feline patent action for BOEHRINGER INGELHEIM ANIMAL HEALTH
Thanks Pandora for following this stuff for the rest of us. Interestingly, the September update noted the successful and significant extension of the anti-aging platform. I presume that is through
...more
(1064)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Sep 16, 2022 1:06am
RE:Tick, tick, tick….
That is a Canadian/France patent. Not sure where you see a reference to TFC-039? "Another object of this invention is a compound as defined above, for use as a drug, in particular as an
...more
(1976)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on Sep 16, 2022 12:30am
Tick, tick, tick….
Patent expiration: TFC-039 April 2029 https://patents.google.com/patent/CA2720011C/en?inventor=Geraldine+Deliencourt-Godefroy
(1976)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Sep 16, 2022 12:19am
RE:Feline patent action for BOEHRINGER INGELHEIM ANIMAL HEALTH
Not a Sirona application... https://patentimages.storage.googleapis.com/d3/87/1a/80baa6f657f6d5/WO2021165177A1.pdf
(1064)
•••
Pandora
X
View Profile
View Bullboard History
Post by
Pandora
on Sep 15, 2022 7:01pm
Feline patent action for BOEHRINGER INGELHEIM ANIMAL HEALTH
Non-final rejection normally means the examiner did not like some things and now the Company has 90 days to respond. USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES
...more
(1064)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Sep 15, 2022 6:12pm
RE:Howhee removing posts again.
How does he do that? Does he contact SH and request a removal. How do they get removed without even being posted? Or are they actually posted for some period of time and then get removed? If so, why
...more
(1976)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Sep 15, 2022 4:13pm
RE:RE:LOOKING PRETTY SICK, HOWHEE!
R+F launched 18 months after deal closed. Same damn timeline for Abbvie?
(9)
•••
Engcan77
X
View Profile
View Bullboard History
Comment by
Engcan77
on Sep 15, 2022 3:53pm
RE:RE:RE:RE:LOOKING PRETTY SICK, HOWHEE!
Well, we've been waiting appox 3 months since the announcement that Dr Bieber was looking to help with a structure change within Sirona. Not sure if it should take 3 months to achieve this goal
...more
(10)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Sep 15, 2022 3:51pm
RE:RE:RE:Definition of sell opportunity?
Correct, it starts with the fancy milestone list and timelines behind which never came into reality. Now they indicated a big people hiring campaign in Vancouver and French but I can't see any job
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Sep 15, 2022 3:42pm
RE:RE:Definition of sell opportunity?
If the share price was still at 34-35 cents, we would not be having any of this discussion. But that, as we know, is not possible without communication.
Prev
...
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >